A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

Clinical trial NCT02202161 · COMPLETED

Trial details

NCT number: NCT02202161
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2014-08-27
Primary completion: 2015-01-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.